334 related articles for article (PubMed ID: 12188908)
1. Cancer-targeted polymeric drugs.
Luo Y; Prestwich GD
Curr Cancer Drug Targets; 2002 Sep; 2(3):209-26. PubMed ID: 12188908
[TBL] [Abstract][Full Text] [Related]
2. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
3. Macromolecular therapeutics: advantages and prospects with special emphasis on solid tumour targeting.
Greish K; Fang J; Inutsuka T; Nagamitsu A; Maeda H
Clin Pharmacokinet; 2003; 42(13):1089-105. PubMed ID: 14531722
[TBL] [Abstract][Full Text] [Related]
4. Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect.
Maeda H; Bharate GY; Daruwalla J
Eur J Pharm Biopharm; 2009 Mar; 71(3):409-19. PubMed ID: 19070661
[TBL] [Abstract][Full Text] [Related]
5. Enhanced permeability and retention of macromolecular drugs in solid tumors: a royal gate for targeted anticancer nanomedicines.
Greish K
J Drug Target; 2007; 15(7-8):457-64. PubMed ID: 17671892
[TBL] [Abstract][Full Text] [Related]
6. Biodegradable polymers for targeted delivery of anti-cancer drugs.
Doppalapudi S; Jain A; Domb AJ; Khan W
Expert Opin Drug Deliv; 2016 Jun; 13(6):891-909. PubMed ID: 26983898
[TBL] [Abstract][Full Text] [Related]
7. Polymeric anticancer drugs with pH-controlled activation.
Ulbrich K; Subr V
Adv Drug Deliv Rev; 2004 Apr; 56(7):1023-50. PubMed ID: 15066758
[TBL] [Abstract][Full Text] [Related]
8. Polymer-drug conjugates: towards a novel approach for the treatment of endrocine-related cancer.
Duncan R; Vicent MJ; Greco F; Nicholson RI
Endocr Relat Cancer; 2005 Jul; 12 Suppl 1():S189-99. PubMed ID: 16113096
[TBL] [Abstract][Full Text] [Related]
9. Polymer-Based Prodrugs: Improving Tumor Targeting and the Solubility of Small Molecule Drugs in Cancer Therapy.
Dragojevic S; Ryu JS; Raucher D
Molecules; 2015 Dec; 20(12):21750-69. PubMed ID: 26690101
[TBL] [Abstract][Full Text] [Related]
10. Designing polymer conjugates as lysosomotropic nanomedicines.
Duncan R
Biochem Soc Trans; 2007 Feb; 35(Pt 1):56-60. PubMed ID: 17233601
[TBL] [Abstract][Full Text] [Related]
11. Anti-Cancer Drug Delivery Using Carbohydrate-Based Polymers.
Ranjbari J; Mokhtarzadeh A; Alibakhshi A; Tabarzad M; Hejazi M; Ramezani M
Curr Pharm Des; 2018 Feb; 23(39):6019-6032. PubMed ID: 28482782
[TBL] [Abstract][Full Text] [Related]
12. Preclinical and clinical studies of anticancer drug-incorporated polymeric micelles.
Matsumura Y
J Drug Target; 2007; 15(7-8):507-17. PubMed ID: 17671897
[TBL] [Abstract][Full Text] [Related]
13. Polymeric nanoparticles for cancer therapy.
Parveen S; Sahoo SK
J Drug Target; 2008 Feb; 16(2):108-23. PubMed ID: 18274932
[TBL] [Abstract][Full Text] [Related]
14. Exploiting EPR in polymer drug conjugate delivery for tumor targeting.
Modi S; Prakash Jain J; Domb AJ; Kumar N
Curr Pharm Des; 2006; 12(36):4785-96. PubMed ID: 17168778
[TBL] [Abstract][Full Text] [Related]
15. Polymer therapeutics and the EPR effect.
Maeda H
J Drug Target; 2017; 25(9-10):781-785. PubMed ID: 28988499
[TBL] [Abstract][Full Text] [Related]
16. Macromolecular Drug Carriers for Targeted Glioblastoma Therapy: Preclinical Studies, Challenges, and Future Perspectives.
Raucher D; Dragojevic S; Ryu J
Front Oncol; 2018; 8():624. PubMed ID: 30619758
[TBL] [Abstract][Full Text] [Related]
17. Macromolecular therapeutics.
Yang J; Kopeček J
J Control Release; 2014 Sep; 190():288-303. PubMed ID: 24747162
[TBL] [Abstract][Full Text] [Related]
18. Self-Assembled Nanocarriers Based on Amphiphilic Natural Polymers for Anti- Cancer Drug Delivery Applications.
Sabra S; Abdelmoneem M; Abdelwakil M; Mabrouk MT; Anwar D; Mohamed R; Khattab S; Bekhit A; Elkhodairy K; Freag M; Elzoghby A
Curr Pharm Des; 2017; 23(35):5213-5229. PubMed ID: 28552068
[TBL] [Abstract][Full Text] [Related]
19. Polymer nanomedicines.
Kopeček J; Yang J
Adv Drug Deliv Rev; 2020; 156():40-64. PubMed ID: 32735811
[TBL] [Abstract][Full Text] [Related]
20. Cancer drug delivery: considerations in the rational design of nanosized bioconjugates.
Kobayashi H; Turkbey B; Watanabe R; Choyke PL
Bioconjug Chem; 2014 Dec; 25(12):2093-100. PubMed ID: 25385142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
